126 related articles for article (PubMed ID: 21091099)
1. Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).
Kozma CM; Dickson M; Raut MK; Mody S; Fisher AC; Schein JR; Mackowiak JI
J Med Econ; 2010; 13(4):719-27. PubMed ID: 21091099
[TBL] [Abstract][Full Text] [Related]
2. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
3. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
4. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital.
McGregor MJ; Reid RJ; Schulzer M; Fitzgerald JM; Levy AR; Cox MB
BMC Health Serv Res; 2006 Nov; 6():152. PubMed ID: 17125520
[TBL] [Abstract][Full Text] [Related]
6. A pneumonia practice guideline and a hospitalist-based reorganization lead to equivalent efficiency gains.
Reddy JC; Katz PP; Goldman L; Wachter RM
Am J Manag Care; 2001 Dec; 7(12):1142-8. PubMed ID: 11767300
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical industry research and cost savings in community-acquired pneumonia.
Kessler LA; Waterer GW; Barca R; Wunderink RG
Am J Manag Care; 2002 Sep; 8(9):798-800. PubMed ID: 12234020
[TBL] [Abstract][Full Text] [Related]
8. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
9. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study.
Fine MJ; Medsger AR; Stone RA; Marrie TJ; Coley CM; Singer DE; Akkad H; Hough LJ; Lang W; Ricci EM; Polenik DM; Kapoor WN
Arch Intern Med; 1997 Jan; 157(1):47-56. PubMed ID: 8996040
[TBL] [Abstract][Full Text] [Related]
10. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
Nathwani D; Rubinstein E; Barlow G; Davey P
Clin Infect Dis; 2001 Mar; 32(5):728-41. PubMed ID: 11229840
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilization in community-acquired pneumonia episodes of care: a comparison across the continuum of managed care.
Landsman PB; Smith DG; Fendrick AM
Med Care; 2009 Oct; 47(10):1084-90. PubMed ID: 19648830
[TBL] [Abstract][Full Text] [Related]
12. Declining length of hospital stay for pneumonia and postdischarge outcomes.
Capelastegui A; España PP; Quintana JM; Gallarreta M; Gorordo I; Esteban C; Urrutia I; Bilbao A
Am J Med; 2008 Oct; 121(10):845-52. PubMed ID: 18823851
[TBL] [Abstract][Full Text] [Related]
13. Admission profile and management of community acquired pneumonia in Nigeria--5 year experience in a tertiary hospital.
Onyedum CC; Chukwuka JC
Respir Med; 2011 Feb; 105(2):298-302. PubMed ID: 21112756
[TBL] [Abstract][Full Text] [Related]
14. [Community-acquired pneumonia: outcomes and costs].
Putinati S; Ballerin L; Gualandi M; Battaglia G; Piattella M; Potena A
Recenti Prog Med; 2002 Mar; 93(3):162-5. PubMed ID: 11942165
[TBL] [Abstract][Full Text] [Related]
15. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia: influence of management practices on length of hospital stay.
Laing R; Coles C; Chambers S; Frampton C; Jennings L; Karalus N; Mills G; Town GI
Intern Med J; 2004 Mar; 34(3):91-7. PubMed ID: 15030455
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
Yu H; Rubin J; Dunning S; Li S; Sato R
J Am Geriatr Soc; 2012 Nov; 60(11):2137-43. PubMed ID: 23110409
[TBL] [Abstract][Full Text] [Related]
18. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000.
Kozlow JH; Berenholtz SM; Garrett E; Dorman T; Pronovost PJ
Crit Care Med; 2003 Jul; 31(7):1930-7. PubMed ID: 12847385
[TBL] [Abstract][Full Text] [Related]
20. Community acquired pneumonia and direct hospital cost.
Doruk S; Tertemiz KC; Kömüs N; Uçan ES; Kilinç O; Sevinç C
Tuberk Toraks; 2009; 57(1):48-55. PubMed ID: 19533437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
